Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Other Accumulated Expenses data on file, last reported at $153.9 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $153.9 million, up 16.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.9 million (up 16.86% YoY), and the FY2025 annual result was $141.7 million, down 3.74% from the prior year.
• Other Accumulated Expenses improved to $153.9 million in Q1 2026 per BIO's latest filing, from $141.7 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $212.7 million in Q2 2022 and troughed at $127.8 million in Q3 2025.
• A 5-year average of $160.0 million and a median of $153.9 million in 2026 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 37.29% in 2022, then decreased 21.85% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $169.6 million in 2022, then slipped by 4.74% to $161.6 million in 2023, then declined by 8.91% to $147.2 million in 2024, then fell by 3.74% to $141.7 million in 2025, then advanced by 8.61% to $153.9 million in 2026.
• Business Quant data shows BIO's Other Accumulated Expenses at $153.9 million in Q1 2026, $141.7 million in Q4 2025, and $127.8 million in Q3 2025.